Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1038/s41571-023-00825-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploring a new pathway for biomarker-based approval of immunotherapies
- (2023) Josep M. Llovet Nature Reviews Clinical Oncology
- Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma
- (2023) Takeshi Yokoo et al. RADIOLOGY
- AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
- (2023) Amit G. Singal et al. HEPATOLOGY
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- (2023) Mary E. Rinella et al. HEPATOLOGY
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
- (2023) Kiyoshi Hasegawa et al. HEPATOLOGY RESEARCH
- Aetiology of liver disease and response to immune checkpoint inhibitors: An updated meta-analysis confirms benefit in those with non-viral liver disease
- (2023) Tim Meyer et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
- (2023) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
- (2023) Frederico Costa et al. Cancer Medicine
- Breakthroughs in Hepatocellular Carcinoma Therapies
- (2023) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Financial Burden of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
- (2023) Manasa Narasimman et al. Clinical Gastroenterology and Hepatology
- Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150
- (2023) Magdalena Espinoza et al. Gastroenterology
- International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance
- (2023) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
- (2023) Shukui Qin et al. LANCET
- Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
- (2023) Shukui Qin et al. JAMA Oncology
- Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma
- (2023) Sarah Cappuyns et al. JAMA Oncology
- Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study
- (2022) Nicolas Chong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
- (2022) Ian Lockart et al. HEPATOLOGY
- Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992‐2018
- (2022) Christian S. Alvarez et al. HEPATOLOGY
- Declining disease burden of HCC in the U nited S tates, 1992–2017: A population‐based analysis
- (2022) Jianglong Han et al. HEPATOLOGY
- Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication
- (2022) Peter P. Mueller et al. JOURNAL OF HEPATOLOGY
- HCC Surveillance Improves Early Detection, Curative Treatment Receipt, and Survival in Patients with Cirrhosis: A Systematic Review and Meta-Analysis
- (2022) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era
- (2022) Atsushi Hiraoka et al. ONCOLOGY
- Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019
- (2022) Yuan Liu et al. Cancer Medicine
- Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
- (2022) Ze-Hong Huang et al. BMC CANCER
- Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study
- (2022) Maedeh Amini et al. BMC PUBLIC HEALTH
- Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States
- (2022) Mohammad A. Karim et al. Clinical Gastroenterology and Hepatology
- Risk factors for HCC in contemporary cohorts of patients with cirrhosis
- (2022) Fasiha Kanwal et al. HEPATOLOGY
- Aspirin Use and the Risk of Hepatocellular Carcinoma
- (2022) Yikai Wang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
- (2022) Freddie Bray et al. LANCET ONCOLOGY
- Changing epidemiology of hepatocellular carcinoma in Asia
- (2022) Chen‐hao Zhang et al. LIVER INTERNATIONAL
- A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
- (2022) Yikai Wang et al. Canadian Journal of Gastroenterology and Hepatology
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
- (2022) Daniel Q. Huang et al. Cell Metabolism
- Hepatocellular Carcinoma Incidence in Alcohol-associated Cirrhosis: Systematic Review and Meta-analysis
- (2022) Daniel Q. Huang et al. Clinical Gastroenterology and Hepatology
- Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
- (2022) Robin Kate Kelley et al. LANCET ONCOLOGY
- Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
- (2022) Andrew X. Zhu et al. NATURE MEDICINE
- TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
- (2022) Andrew M. Brown et al. Cancer Medicine
- Hepatocellular Carcinoma in Africa: Challenges and Opportunities
- (2022) Mohamed El-Kassas et al. Frontiers in Medicine
- Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
- (2022) Neehar D. Parikh et al. JAMA Network Open
- Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition
- (2022) Shen Zhang et al. World Journal of Gastrointestinal Surgery
- LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
- (2022) R.S. Finn et al. ANNALS OF ONCOLOGY
- Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
- (2022) Laura Torrens et al. CLINICAL CANCER RESEARCH
- Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
- (2022) Darren Jun Hao Tan et al. HEPATOLOGY
- Global burden of primary liver cancer in 2020 and predictions to 2040
- (2022) Harriet Rumgay et al. JOURNAL OF HEPATOLOGY
- Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
- (2022) Neehar D. Parikh et al. JOURNAL OF HEPATOLOGY
- Hepatocellular Carcinoma Chemoprevention with Generic Agents
- (2022) Fahmida Rasha et al. SEMINARS IN LIVER DISEASE
- Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality
- (2022) Hyun-seok Kim et al. JAMA Network Open
- Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma
- (2022) Fabrizio Di Benedetto et al. JAMA Surgery
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters
- (2021) Sean A. Woolen et al. Clinical Gastroenterology and Hepatology
- International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
- (2021) Amit G. Singal et al. GASTROENTEROLOGY
- Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis
- (2021) Pankaj Gupta et al. JOURNAL OF HEPATOLOGY
- Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity
- (2021) Vinod K. Rustgi et al. GASTROENTEROLOGY
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study
- (2021) Riad Salem et al. HEPATOLOGY
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Etiologies and outcomes of cirrhosis in a large contemporary cohort
- (2021) Hannes Hagström et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
- (2021) Karim J. Halazun et al. JAMA Surgery
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
- (2021) E.A. Klein et al. ANNALS OF ONCOLOGY
- Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
- (2021) Haley Schoenberger et al. Clinical Gastroenterology and Hepatology
- Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma
- (2021) Naga P. Chalasani et al. Clinical Gastroenterology and Hepatology
- Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
- (2021) Philipp K. Haber et al. GASTROENTEROLOGY
- Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium
- (2021) Neil Mehta et al. GASTROENTEROLOGY
- IMbrave150: Exploratory analysis to examine the association between treatment response and overall survival (OS) in patients (pts) with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor).
- (2021) Michel Ducreux et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention
- (2021) Naomi F. Lange et al. JOURNAL OF HEPATOLOGY
- Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States
- (2021) Hyun-seok Kim et al. JOURNAL OF HEPATOLOGY
- Meta-Analysis of the Accuracy of Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Non-Contrast versus Hepatobiliary Phase-Abbreviated Magnetic Resonance Imaging
- (2021) Dong Hwan Kim et al. Cancers
- Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations
- (2021) David T. Fetzer et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression
- (2021) Lorenzo A. Orci et al. Clinical Gastroenterology and Hepatology
- Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance
- (2021) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma
- (2021) Haley Schoenberger et al. Clinical Gastroenterology and Hepatology
- Global, regional and national burden of primary liver cancer by subtype
- (2021) Harriet Rumgay et al. EUROPEAN JOURNAL OF CANCER
- Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
- (2021) Nicole E. Rich et al. HEPATOLOGY
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high‐risk patients
- (2021) Hyo Jung Park et al. LIVER INTERNATIONAL
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Current epidemiology in hepatocellular carcinoma
- (2021) Peter Konyn et al. Expert Review of Gastroenterology & Hepatology
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi‐center cohort of patients with cirrhosis
- (2020) Nicole E. Rich et al. HEPATOLOGY
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- The Changing Epidemiology of Hepatocellular Carcinoma : Experience of a Single Center
- (2020) Lydia Giannitrapani et al. Biomed Research International
- Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2020) Neehar D Parikh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018
- (2020) Donghee Kim et al. GASTROENTEROLOGY
- Global Burden of 5 Major Types Of Gastrointestinal Cancer
- (2020) Melina Arnold et al. GASTROENTEROLOGY
- Utilization of hepatocellular carcinoma surveillance in patients with cirrhosis: A systematic review and meta‐analysis
- (2020) Erin Wolf et al. HEPATOLOGY
- Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review
- (2020) Cheng‐Hao Tseng et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
- (2020) Alexander J. Stockdale et al. JOURNAL OF HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
- (2020) Masatoshi Kudo et al. Liver Cancer
- Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma
- (2020) Nicole E. Rich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cost-Effectiveness of Hepatocellular Carcinoma Surveillance
- (2020) Neehar D. Parikh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- Patient-Reported Barriers are Associated with Receipt of Hepatocellular Carcinoma Surveillance in a Multi-Center Cohort of Patients with Cirrhosis
- (2020) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis
- (2020) Peter Jepsen et al. JOURNAL OF HEPATOLOGY
- Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
- (2020) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study
- (2020) Xiaojun Ge et al. BMJ Open
- A Comparison of Biannual Two-Phase Low-Dose Liver CT and US for HCC Surveillance in a Group at High Risk of HCC Development
- (2020) Jeong Hee Yoon et al. Liver Cancer
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Racial and Ethnic Disparities in Survival Among Patients with Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis
- (2020) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
- (2020) John D. Gordan et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
- (2020) Etienne Garin et al. Lancet Gastroenterology & Hepatology
- The National Institute on Minority Health and Health Disparities Research Framework
- (2019) Jennifer Alvidrez et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients
- (2019) Emma Nilsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States
- (2019) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Unexpected Rapid Increase in the Burden of Nonalcoholic Fatty Liver Disease in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
- (2019) Feng Zhou et al. HEPATOLOGY
- Adiponectin accounts for gender differences in hepatocellular carcinoma incidence
- (2019) Elisa Manieri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores
- (2019) George N. Ioannou et al. GASTROENTEROLOGY
- Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- National Experience on Down‐staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP , and Wait Time
- (2019) Neil Mehta et al. HEPATOLOGY
- Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
- (2019) Mark Yarchoan et al. CANCER RESEARCH
- Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
- (2019) Jens Ricke et al. JOURNAL OF HEPATOLOGY
- Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
- (2019) Jian Lu et al. Lancet Gastroenterology & Hepatology
- Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
- (2019) Zhijiang Miao et al. JOURNAL OF INFECTIOUS DISEASES
- TCT-472 Distribution of Coronary Flow Capacity Is Different Among the Groups by Abnormal CFR/HMR in Nonobstructive Coronary Artery Disease Patients
- (2019) Jin-Sin Koh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma
- (2019) Yong Xia et al. JAMA Oncology
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Global timing of hepatitis C virus elimination in high‐income countries
- (2019) Homie Razavi et al. LIVER INTERNATIONAL
- Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
- (2018) Jessica L. Petrick et al. BRITISH JOURNAL OF CANCER
- Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
- (2018) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
- (2018) Delphine Maucort-Boulch et al. INTERNATIONAL JOURNAL OF CANCER
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study
- (2018) Mindie H Nguyen et al. JOURNAL OF INFECTIOUS DISEASES
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance
- (2018) Okeefe L. Simmons et al. Clinical Gastroenterology and Hepatology
- Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients with Cirrhosis: A Randomized Clinical Trial
- (2018) Amit G. Singal et al. HEPATOLOGY
- Cost-effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With HCV Infection and Advanced Fibrosis
- (2018) Hooman Farhang Zangneh et al. Clinical Gastroenterology and Hepatology
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Coffee and the risk of hepatocellular carcinoma and chronic liver disease
- (2017) Francesca Bravi et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
- (2017) Alvin W. T. Ng et al. Science Translational Medicine
- Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
- (2017) Nicolas Goossens et al. Clinical and Translational Gastroenterology
- MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma
- (2017) So Yeon Kim et al. JAMA Oncology
- Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
- (2016) Sarah Berhane et al. Clinical Gastroenterology and Hepatology
- Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
- (2016) Riad Salem et al. GASTROENTEROLOGY
- An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis
- (2016) Omair Atiq et al. HEPATOLOGY
- Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
- (2016) Riccardo Lencioni et al. HEPATOLOGY
- Length time bias in surveillance for hepatocellular carcinoma and how to avoid it
- (2016) Alessandro Cucchetti et al. HEPATOLOGY RESEARCH
- PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
- (2016) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
- (2016) Riccardo Lencioni et al. JOURNAL OF HEPATOLOGY
- Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis
- (2016) Elena Raffetti et al. LIVER INTERNATIONAL
- Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
- (2016) Luis A. García Rodríguez et al. PLoS One
- The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition
- (2015) Krasimira Aleksandrova et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B
- (2015) Ju Dong Yang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
- (2015) Amit G. Singal et al. AMERICAN JOURNAL OF MEDICINE
- Recurrence of Hepatocellular Cancer After Resection
- (2015) Parissa Tabrizian et al. ANNALS OF SURGERY
- Changing epidemiology of hepatocellular carcinoma in Asia
- (2015) George Boon-Bee Goh et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Improved Surveillance for Hepatocellular Carcinoma With a Primary Care–Oriented Clinical Reminder
- (2015) Lauren A. Beste et al. Clinical Gastroenterology and Hepatology
- Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
- (2015) Francis Y. Yao et al. HEPATOLOGY
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
- (2015) Anna S.F. Lok et al. HEPATOLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion
- (2015) Jian-Hong Zhong et al. MEDICINE
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
- (2015) Bruno Vincenzi et al. PLoS One
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Screening for Hepatocellular Carcinoma in Chronic Liver Disease
- (2014) Devan Kansagara et al. ANNALS OF INTERNAL MEDICINE
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
- (2014) R Golfieri et al. BRITISH JOURNAL OF CANCER
- Molecular targets of aspirin and cancer prevention
- (2014) L Alfonso et al. BRITISH JOURNAL OF CANCER
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
- (2014) Masatoshi Kudo et al. HEPATOLOGY
- Statin use and risk of liver cancer: an update meta-analysis
- (2014) M. Shi et al. BMJ Open
- Efficacy of Neonatal HBV Vaccination on Liver Cancer and Other Liver Diseases over 30-Year Follow-up of the Qidong Hepatitis B Intervention Study: A Cluster Randomized Controlled Trial
- (2014) Chunfeng Qu et al. PLOS MEDICINE
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- (2014) Amit G. Singal et al. PLOS MEDICINE
- Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
- (2013) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
- (2013) A M Attallah et al. BRITISH JOURNAL OF CANCER
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Resection of Hepatocellular Carcinoma Without Cirrhosis
- (2012) Brian Shrager et al. ANNALS OF SURGERY
- Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis
- (2012) Yan Liu et al. EUROPEAN JOURNAL OF CANCER
- Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
- (2012) Sasan Roayaie et al. HEPATOLOGY
- Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
- (2012) Vincenzo Mazzaferro et al. HEPATOLOGY
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
- (2012) Kai Feng et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma
- (2011) J. S.-W. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
- (2011) Emily Jane Gallagher et al. Annals of the New York Academy of Sciences
- The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
- (2011) Katherine A. McGlynn et al. Clinics in Liver Disease
- Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
- (2011) Jean-Claude Trinchet et al. HEPATOLOGY
- Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males
- (2011) Donna L. White et al. HEPATOLOGY
- Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?
- (2011) Hossein Poustchi et al. HEPATOLOGY
- Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control Study
- (2011) D. Trichopoulos et al. JNCI-Journal of the National Cancer Institute
- Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection
- (2010) W. Alazawi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
- (2010) Valentina Santi et al. JOURNAL OF HEPATOLOGY
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
- (2009) Mei-Hwei Chang et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now